Malaria vaccine - Aventis Pasteur/WRAIR
Alternative Names: NYVAC-Pf7ALatest Information Update: 06 Apr 2022
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; sanofi pasteur
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Falciparum malaria
Most Recent Events
- 24 Dec 1999 Pasteur Mérieux Connaught is now a subsidiary of Aventis and its new name is Aventis Pasteur
- 12 Mar 1999 New profile, split from generic Malaria vaccine profile
- 12 Mar 1999 Phase-II clinical trials for Falciparum malaria in France (Unknown route)